Edwards Lifesciences (NYSE:EW) SVP Sells 544 Shares of Stock
MarketBeat
Andrew Dahl, SVP of Edwards Lifesciences (NYSE:EW), sold 544 shares of the company's stock for approximately $49,537, reducing his stake by 3.53%. This insider sale comes as Edwards Lifesciences reported strong quarterly earnings, beating EPS estimates by $0.04 and seeing revenue increase by 13.6% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating for the stock, with an average price target of $100.27.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.